[1] |
Boer, H., Holland, A., Whittington, J. et al. Psychotic illness in people with Prader–Willi syndrome due to chromosome 15 maternal uniparental disomy Lancet, 359 (2002),pp. 135-136
|
[2] |
Butler, J.V., Whittington, J.E., Holland, A.J. et al. Prevalence of and risk factors for physical ill health in people with Prader–Willi syndrome: a population based study Dev. Med. Child Neurol., 44 (2002),pp. 248-255
|
[3] |
Carrel, A.L., Myers, S.E., Whitman, B.Y. et al. Benefits of long-term GH therapy in Prader–Willi syndrome: a 4-year study J. Clin. Endocrinol. Metab., 87 (2002),pp. 1582-1585
|
[4] |
Clarke, D.J., Boer, H. Genetic and behavioural aspects of Prader–Willi syndrome: a review with translation of the original paper Ment. Handicap. Res., 8 (1995),pp. 38-53
|
[5] |
De Smith, A.J., Purmann, C., Walters, R.G. et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism Hum. Mol. Genet., 17 (2009),pp. 3257-3265
|
[6] |
Eiholzer, U., Schlumpf, M., Nordmann, Y. et al. Early manifestations of Prader–Willi syndrome: influence of growth hormone J. Pediatr. Endocrinol. Metab., 14 (2001),pp. 1441-1444
|
[7] |
Gillessen Kaesbach, G., Robinson, W., Lohmann, D. et al. Genotype–phenotype correlation in a series of 167 deletion and non-deletion patients with Prader–Willi syndrome Hum. Genet., 96 (1995),pp. 638-643
|
[8] |
Gunay-Aygun, M., Schwartz, S., Heeger, S. et al. The changing purpose of Prader–Willi syndrome clinical diagnostic criteria and proposed revised criteria Pediatrics, 108 (2001),p. e92
|
[9] |
Hamabe, J., Fukushima, Y., Harada, N. et al. Molecular study of the Prader–Willi syndrome: deletion, RFLP, and phenotype analyses of 50 patients Am. J. Hum. Genet., 41 (1991),pp. 54-63
|
[10] |
Holm, V.A., Cassidy, S.B., Butler, M.G. Prader–Willi syndrome: consensus diagnostic criteria Pediatrics, 93 (1993),pp. 398-402
|
[11] |
Lin, H.Y., Lin, S.P., Chuang, C.K. et al. Genotype and phenotype in patients with Prader–Willi Syndrome in Taiwan Acta Pediatr., 96 (2007),pp. 902-905
|
[12] |
Matsubara, K., Murakami, N., Nagai, T. et al. Maternal age effect on the development of Prader–Willi syndrome resulting from upd(15)mat through meiosis 1 errors J. Hum. Genet., 1 (2011),pp. 1-6
|
[13] |
Kim, H.J., Cho, H.J., Jin, D.K. et al. Genetic basis of Prader–Willi syndrome in Korea: less uniparental disomy than has been recognized? Clin. Genet., 72 (2004),pp. 368-372
|
[14] |
Ledbetter, D.H., Riccardi, V.M., Airhart, S.D. et al. Deletions of chromosome 15 as a cause of the Prader–Willi syndrome N. Engl. J. Med., 304 (1981),pp. 304-325
|
[15] |
Mitchell, J., Schinzel, A., Langlois, S. et al. Comparison of phenotype in uniparental disomy and deletion Prader–Willi syndrome: sex specific differences Am. J. Med. Genet., 65 (1996),pp. 133-136
|
[16] |
Rinchik, E.M., Bultman, S.J., Horsthemke, B. et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism Nature, 361 (1993),pp. 72-76
|
[17] |
Sahoo, T., del Gaudio, D., German, J.R. et al. Prader–Willi phenotype caused by paternal deficiency for the HBIl-85 C/D box small nucleolar RNA cluster Nat. Genet., 40 (2008),pp. 719-721
|
[18] |
Vogels, A., Van Den Ende, J., Keymolen, K. et al. Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders Eur. J. Hum. Genet., 12 (2004),pp. 238-240
|
[19] |
Whittington, J.E., Holland, A.J., Webb, T. et al. Population prevalence and estimated birth incidence and mortality rate for people with Prader–Willi syndrome in one UK Health Region J. Med. Genet., 11 (2001),pp. 792-798
|